about
ZAP70: a master regulator of adaptive immunityForce generation upon T cell receptor engagementThe Ets-1 transcription factor controls the development and function of natural regulatory T cells.Development of autoantibodies against muscle-specific FHL1 in severe inflammatory myopathies.A Novel HLA-DRB1*10:01-Restricted T Cell Epitope From Citrullinated Type II Collagen Relevant to Rheumatoid Arthritis.Hypomorphic mutation of ZAP70 in human results in a late onset immunodeficiency and no autoimmunity.Diminished CXCR5 expression in peripheral blood of patients with Sjögren's syndrome may relate to both genotype and salivary gland homing.VAMP7 controls T cell activation by regulating the recruitment and phosphorylation of vesicular Lat at TCR-activation sites.Detection and follow-up of fibroblast growth factor receptor 3 expression on bone marrow and circulating plasma cells by flow cytometry in patients with t(4;14) multiple myeloma.T cell polarity at the immunological synapse is required for CD154-dependent IL-12 secretion by dendritic cells.Cognate CD4+ T-cell-dendritic cell interactions induce migration of immature dendritic cells through dissolution of their podosomesDifferential ACPA Binding to Nuclear Antigens Reveals a PAD-Independent Pathway and a Distinct Subset of Acetylation Cross-Reactive Autoantibodies in Rheumatoid ArthritisSystematic approach demonstrates enrichment of multiple interactions between non-HLA risk variants and HLA-DRB1 risk alleles in rheumatoid arthritis.The development of early and mature B cells is impaired in mice deficient for the Ets-1 transcription factorThe Ets-1 transcription factor is required for Stat1-mediated T-bet expression and IgG2a class switching in mouse B cellsFoxP3+ CXCR5+ CD4+ T cell frequencies are increased in peripheral blood of patients with primary Sjögren's syndrome
P50
Q24298531-988FE6FF-F23A-4FEE-850D-155F609B9AF8Q27342631-A63B6F47-F11C-40CA-873D-C71A2B2902F8Q34161509-EA054D7D-7946-4F19-B795-2D1D8186470DQ36335887-DD32D8D0-D7CD-46B0-B356-683BBD19B372Q45024239-59FE8609-7707-4D95-823A-D1137F7B3C17Q45957471-0D3550FB-989B-49F9-8C27-149ED5AF3EF8Q49906688-942F5A23-667E-4B71-AF1B-8267A8600B3CQ51000427-05AB2C17-A001-4C15-B0E7-7591C90039C5Q54562253-F3B24926-792F-4384-8784-60B0CC9CAEB6Q54637817-3D7534BB-30F2-4650-9BC3-510E2498F63CQ58470464-AEF61E7C-D105-4379-A68D-FA67EC4EC01BQ60920704-F3EBC96D-AFE3-4F7D-B5CC-9C67E7E0D930Q64883875-915A64FF-051D-4EB5-A94B-D0ABFDCF3A60Q80598197-D5963404-23AD-4529-9562-A6CE28CEE75AQ83720383-064B219E-0850-46CF-9BC8-41861BBFB7B1Q90994338-04969152-A91B-4B03-95E9-F74C97A06D8B
P50
description
onderzoeker
@nl
researcher, ORCID id # 0000-0002-2597-7809
@en
name
Karine Chemin
@ast
Karine Chemin
@en
Karine Chemin
@es
Karine Chemin
@nl
type
label
Karine Chemin
@ast
Karine Chemin
@en
Karine Chemin
@es
Karine Chemin
@nl
prefLabel
Karine Chemin
@ast
Karine Chemin
@en
Karine Chemin
@es
Karine Chemin
@nl
P106
P21
P2798
P31
P496
0000-0002-2597-7809